Details for Patent: 11,613,511
✉ Email this page to a colleague
Which drugs does patent 11,613,511 protect, and when does it expire?
Patent 11,613,511 protects NEXLETOL and NEXLIZET and is included in two NDAs.
This patent has twenty-one patent family members in ten countries.
Drugs Protected by US Patent 11,613,511
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Theraps Inc | NEXLETOL | bempedoic acid | TABLET;ORAL | 211616-001 | Feb 21, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Esperion Theraps Inc | NEXLIZET | bempedoic acid; ezetimibe | TABLET;ORAL | 211617-001 | Feb 26, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,613,511
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020295503 | ⤷ Sign Up | |||
| Australia | 2020296094 | ⤷ Sign Up | |||
| Brazil | 112021025928 | ⤷ Sign Up | |||
| Brazil | 112021025964 | ⤷ Sign Up | |||
| Canada | 3144371 | ⤷ Sign Up | |||
| Canada | 3144372 | ⤷ Sign Up | |||
| China | 112437765 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
